Quote:

---

Potential path could mean many things. It could be a approval might come if you were to agree to a deal of all doses currently in hand are to be used in the USA. That’s one example. It could be as simple as a EUA approval with a phase 4 confirmation follow up that’s another potential path

---

Either of those would have been announced in the PR. Cytodyn would not shy away from trumpeting those to the high heavens. Announcement of DSMC results in a CC only makes sense in terms of softening the blow. Yes, trial continuation is positive but not compared to an interim EUA submission.